Arbutus Biopharma Corporation Earning Date (ABUS)

USA |NASDAQ |USD

ABUS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 $-0.16 $-0.11 $-0.23
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 $5.54M $12.58M $2.33M

Arbutus Biopharma Corporation's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

ABUS Earnings Date & History Chart

ABUS Earnings & Revenue Forecast

ABUS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 5 $-0.16 $-0.19 $-0.08
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-0.64 $-0.77 $-0.31
Dec 2023 5 $-0.66 $-0.93 $-0.30

ABUS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $-0.17 $-0.17 $-0.18
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-0.70 $-0.71 $-0.73
Dec 2023 0 / 0 $-0.75 $-0.56 $-0.70

ABUS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 5 $5.54M $3.20M $8.70M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $20.60M $12.80M $34.25M
Dec 2023 5 $22.60M $12.80M $37.28M

ABUS Earnings Date & Revenue History

ABUS Earnings History

|
Show More
Show More

ABUS Revenue History

|
Show More
Show More

Arbutus Biopharma Corporation Next Earnings Date & Report

ABUS Next Earnings Date & Report Preview: Jun 2022 (FQ)

ABUS's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Arbutus Biopharma Corporation's next quarterly earnings is $-0.16, with a low EPS estimation of $-0.19, and a high estimation of $-0.08.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.17, the last 2 month trend is $-0.17, and the 3 month trend is $-0.18.

Based on analysts, the average revenue estimation is $5.54M, with a low revenue estimation of $3.20M, and a high estimation of $8.70M.

Arbutus Biopharma Corporation Previous Earnings Dates & Reports

ABUS Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Arbutus Biopharma Corporation's previous earnings date was May 5, 2022 for its fiscal quarter ended Mar 31, 2022.

ABUS's earnings per share (EPS) was $-0.11, beating the consensus analysts forecast of $-0.16 by 31.25%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by -26.67%, and higher than the same period a year before (Mar 2021) by -47.84%.

Revenues were $12.58M, better than the forecast of $4.37M by 187.89%, up by 292.42% from the previous quarter , and up by 495.41% from the same period last year.

The company reported a net income of $-15.77M.

Free cash flow for the quarter was $20.62B , compared to $-19.66M last quarter and $-17.98M a year before.

ABUS Previous Earnings Date & Report Recap: Dec 2021 (FY)

Arbutus Biopharma Corporation's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.

ABUS's earnings per share (EPS) was $-0.83, beating the consensus analysts forecast of $-0.86 by -3.38% , and higher than the previous year's EPS (Dec 2020) by -16.74%.

Revenues were $10.99M, better than the forecast of $10.67M by 2.98%, and up by 58.92% from previous year's revenue.

The company reported a net income of $-76.25M.

Arbutus Biopharma Corporation reported a free cash flow of $-67.53M for its fiscal year, compared to $-51.67M a year ago.

The company ended the fiscal year with $383.00K in total debt, a decrease of -87.16% compared to the previous year.